ASHLEY LONG: Open Payments
NPI 1609185859 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 11 payments from 8 companies in 2025. Trend: 2023 $154 · 2024 $335 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $215 |
| Gilead Sciences, Inc. | 2 | $44 |
| Boston Scientific Corporation | 2 | $42 |
| Ardelyx, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: REZDIFFRA, WATCHMAN FLX, IBSRELA, LINZESS, XIFAXAN, TREMFYA.
Industry payments across MS — which companies pay providers there.
